Bramshill Investments’s Novartis NVS Stock Holding History

Bramshill Investments’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-119	Closed	-$9K	–	160
2018 Q4	$9K	Buy	119 +20	+20%	+$1.56K	﹤0.01%	169
2018 Q3	$8K	Buy	+99	New	+$7.32K	﹤0.01%	183

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bramshill Investments's NVS Position: Q1 2019 in Review

Bramshill Investments sold out of Novartis (NVS) in Q1 2019, closing a stake of 119 shares — an estimated $9K sold.

Bramshill Investments first reported a position in NVS in Q3 2018 and held it in 2 quarters. The position peaked at $9K in Q4 2018. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

Bramshill Investments reported no remaining Novartis position as of Q1 2019 after selling out during the quarter.
Bramshill Investments sold 119 Novartis shares in Q1 2019, an estimated $9K.
Bramshill Investments first reported a position in Novartis in Q3 2018 and held it in 2 quarters.
Bramshill Investments's Novartis position peaked at $9K in Q4 2018.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on Bramshill Investments's 13F filing for Q1 2019, filed 15 May 2019.